Our business development strategy is focused on in-licensing and commercial partnerships of late-stage assets (late Phase 3, in registration, on market) in supportive care related to cancer and other therapy areas, as well as in niche oncology and specialized dermatology.
We ensure that our partners are supported through every stage of development. Through our comprehensive platform, we offer a value-added approach able to bring our in-licensed assets across regulatory, manufacturing and commercial phases.
Our goal is to be the partner of choice for biotech and pharmaceutical companies focused on supportive care for patients with cancer and chronic diseases.
We build, launch and commercialize solid brands globally with a strong focus on supportive care, able to reach patients worldwide through our extensive commercial and supply network, leveraging our integrated platform based on broad technical expertise.
Helsinn Healthcare SA. All rights reserved. Helsinn Group 2025 ©
Please click ‘Continue to external site’ if you want to continue.
